PortfoliosLab logo
PGNY vs. NNOX
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between PGNY and NNOX is 0.43, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


-0.50.00.51.0
Correlation: 0.4

Performance

PGNY vs. NNOX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Progyny, Inc. (PGNY) and Nano-X Imaging Ltd. (NNOX). The values are adjusted to include any dividend payments, if applicable.

-80.00%-70.00%-60.00%-50.00%-40.00%-30.00%-20.00%NovemberDecember2025FebruaryMarchApril
-22.06%
-75.48%
PGNY
NNOX

Key characteristics

Sharpe Ratio

PGNY:

-0.52

NNOX:

-0.51

Sortino Ratio

PGNY:

-0.34

NNOX:

-0.41

Omega Ratio

PGNY:

0.94

NNOX:

0.96

Calmar Ratio

PGNY:

-0.39

NNOX:

-0.43

Martin Ratio

PGNY:

-0.83

NNOX:

-1.13

Ulcer Index

PGNY:

36.82%

NNOX:

36.34%

Daily Std Dev

PGNY:

59.45%

NNOX:

81.17%

Max Drawdown

PGNY:

-79.49%

NNOX:

-95.41%

Current Drawdown

PGNY:

-65.65%

NNOX:

-94.05%

Fundamentals

Market Cap

PGNY:

$1.91B

NNOX:

$325.19M

EPS

PGNY:

$0.58

NNOX:

-$0.93

PS Ratio

PGNY:

1.64

NNOX:

28.82

PB Ratio

PGNY:

4.44

NNOX:

1.68

Total Revenue (TTM)

PGNY:

$889.14M

NNOX:

$11.73M

Gross Profit (TTM)

PGNY:

$190.96M

NNOX:

-$11.45M

EBITDA (TTM)

PGNY:

$49.69M

NNOX:

-$34.78M

Returns By Period

In the year-to-date period, PGNY achieves a 32.75% return, which is significantly higher than NNOX's -26.11% return.


PGNY

YTD

32.75%

1M

6.56%

6M

47.27%

1Y

-29.75%

5Y*

2.02%

10Y*

N/A

NNOX

YTD

-26.11%

1M

-9.83%

6M

-7.16%

1Y

-41.47%

5Y*

N/A

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

PGNY vs. NNOX — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

PGNY
The Risk-Adjusted Performance Rank of PGNY is 2727
Overall Rank
The Sharpe Ratio Rank of PGNY is 2323
Sharpe Ratio Rank
The Sortino Ratio Rank of PGNY is 2828
Sortino Ratio Rank
The Omega Ratio Rank of PGNY is 2424
Omega Ratio Rank
The Calmar Ratio Rank of PGNY is 2828
Calmar Ratio Rank
The Martin Ratio Rank of PGNY is 3434
Martin Ratio Rank

NNOX
The Risk-Adjusted Performance Rank of NNOX is 2525
Overall Rank
The Sharpe Ratio Rank of NNOX is 2424
Sharpe Ratio Rank
The Sortino Ratio Rank of NNOX is 2626
Sortino Ratio Rank
The Omega Ratio Rank of NNOX is 2929
Omega Ratio Rank
The Calmar Ratio Rank of NNOX is 2525
Calmar Ratio Rank
The Martin Ratio Rank of NNOX is 2424
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

PGNY vs. NNOX - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Progyny, Inc. (PGNY) and Nano-X Imaging Ltd. (NNOX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The chart of Sharpe ratio for PGNY, currently valued at -0.52, compared to the broader market-2.00-1.000.001.002.003.00
PGNY: -0.52
NNOX: -0.51
The chart of Sortino ratio for PGNY, currently valued at -0.34, compared to the broader market-6.00-4.00-2.000.002.004.00
PGNY: -0.34
NNOX: -0.41
The chart of Omega ratio for PGNY, currently valued at 0.94, compared to the broader market0.501.001.502.00
PGNY: 0.94
NNOX: 0.96
The chart of Calmar ratio for PGNY, currently valued at -0.39, compared to the broader market0.001.002.003.004.005.00
PGNY: -0.39
NNOX: -0.43
The chart of Martin ratio for PGNY, currently valued at -0.83, compared to the broader market-10.00-5.000.005.0010.0015.0020.00
PGNY: -0.83
NNOX: -1.13

The current PGNY Sharpe Ratio is -0.52, which is comparable to the NNOX Sharpe Ratio of -0.51. The chart below compares the historical Sharpe Ratios of PGNY and NNOX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.00-0.500.000.50NovemberDecember2025FebruaryMarchApril
-0.52
-0.51
PGNY
NNOX

Dividends

PGNY vs. NNOX - Dividend Comparison

Neither PGNY nor NNOX has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

PGNY vs. NNOX - Drawdown Comparison

The maximum PGNY drawdown since its inception was -79.49%, smaller than the maximum NNOX drawdown of -95.41%. Use the drawdown chart below to compare losses from any high point for PGNY and NNOX. For additional features, visit the drawdowns tool.


-100.00%-90.00%-80.00%-70.00%-60.00%NovemberDecember2025FebruaryMarchApril
-65.65%
-94.05%
PGNY
NNOX

Volatility

PGNY vs. NNOX - Volatility Comparison

The current volatility for Progyny, Inc. (PGNY) is 10.54%, while Nano-X Imaging Ltd. (NNOX) has a volatility of 26.75%. This indicates that PGNY experiences smaller price fluctuations and is considered to be less risky than NNOX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%20.00%25.00%30.00%35.00%40.00%NovemberDecember2025FebruaryMarchApril
10.54%
26.75%
PGNY
NNOX

Financials

PGNY vs. NNOX - Financials Comparison

This section allows you to compare key financial metrics between Progyny, Inc. and Nano-X Imaging Ltd.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items